Pnc Financial Services Group, Inc. Maxcyte, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $143 Billion
- Q1 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 6,255 shares of MXCT stock, worth $25,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,255
Previous 6,255
-0.0%
Holding current value
$25,332
Previous $29,000
10.34%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
126Shares Held
62MCall Options Held
2.4KPut Options Held
2.1K-
Black Rock Inc. New York, NY7.23MShares$29.3 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY6.56MShares$26.6 Million0.98% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.17MShares$25 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$21.7 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$20.4 Million6.7% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $412M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...